Trials / Completed
CompletedNCT05410873
Examining the Effects of Mitochondrial Oxidative Stress in DCM
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Double blind, randomised, placebo-controlled trial of MitoQ (mitoquinol mesylate) in 106 patients with dilated cardiomyopathy, examining the effect of reducing mitochondrial oxidative stress on myocardial energetics and myocardial function using 31-phosphorus magnetic resonance spectroscopy and cardiovascular magnetic resonance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MitoQ Compound | Mitoquinol mesylate |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2022-07-26
- Primary completion
- 2024-06-19
- Completion
- 2024-06-19
- First posted
- 2022-06-08
- Last updated
- 2025-09-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05410873. Inclusion in this directory is not an endorsement.